<div class="welcome-screen" id="welcomeScreen">
    <div class="welcome-banner">
        <h1 id="welcome-title">Welcome to the page on hypersensitivity!</h1>
        <p id="welcome-description">Explore the the reactions, antibodies and the like.</p>
    </div>
    
    <!-- INTRODUCTION TO HYPERSENSITIVITY -->
    <div class="explanation-card">
        <h1>Introduction to Hypersensitivity: Immune Overreaction</h1>
        <p><b>Hypersensitivity</b> refers to excessive, harmful immune responses to exogenous or endogenous antigens, classified by Gell and Coombs into <b>four types (I–IV)</b>. These reactions arise from the interplay of <b>antibodies, T cells, and inflammatory mediators</b>, often targeting benign substances (e.g., pollen, food).</p>

        <h2>Historical Context</h2>
        <p>The term "allergy" was coined by <b>Clemens von Pirquet</b> in 1906 to describe altered immune reactivity. The Gell-Coombs classification (1963) organized hypersensitivity by <b>mechanism</b> rather than clinical presentation.</p>

        <h2>Key Immune Components</h2>
        <p><b>Mast cells, eosinophils, IgE, and Th2 cells</b> dominate <b>Type I</b>, while <b>IgG/IgM, complement, and cytotoxic T cells</b> drive <b>Types II–IV</b>. Dysregulation of these pathways underlies diseases ranging from <b>anaphylaxis</b> to <b>autoimmune vasculitis</b>.</p>

        <div class="mnemonic">
        <h4>Mnemonic: "Allergy Starts Fast, Then Slows Down"</h4>
        <p><b>Type I</b> = Fast (minutes) | <b>Types II/III</b> = Intermediate (hours-days) | <b>Type IV</b> = Slow (days).</p>
        </div>
    </div>

    <div class="question-card">
        <h1>Question 1</h1>
        <p>Which immune cell is MOST central to Type I hypersensitivity?</p>
        <ul class="options" id="options">
        <li data-answer="wrong">CD8+ T cells</li>
        <li data-answer="correct">Mast cells</li>
        <li data-answer="wrong">Neutrophils</li>
        </ul>
    </div>

    <!-- ANTIBODIES AND THEIR ROLES -->
    <div class="explanation-card">
        <h1>Antibodies in Hypersensitivity: Structure and Function</h1>
        <p>Antibodies (<b>immunoglobulins</b>) mediate hypersensitivity via <b>antigen recognition</b> and <b>effector functions</b>:</p>

        <h2>1. IgE (Type I)</h2>
        <p><b>Structure</b>: Monomeric with high-affinity FcεRI binding sites. <b>Function</b>: Binds mast cells/basophils; cross-linking by antigen triggers <b>histamine release</b>.</p>

        <h2>2. IgG/IgM (Types II/III)</h2>
        <p><b>Structure</b>: IgG (monomeric), IgM (pentameric). <b>Function</b>: 
        <ol>
        <li><b>Opsonization</b> (FcγR-mediated phagocytosis).</li>
        <li><b>Complement activation</b> (classical pathway → C3a/C5a).</li>
        <li><b>Antibody-dependent cellular cytotoxicity (ADCC)</b> (e.g., IgG + NK cells).</li>
        </ol>
        </p>

        <h2>3. IgA (Rare Hypersensitivity)</h2>
        <p><b>Structure</b>: Dimeric in mucosa. <b>Function</b>: Can cause <b>IgA vasculitis</b> (Henoch-Schönlein purpura) via immune complex deposition.</p>

        <div class="mnemonic">
        <h4>Mnemonic: "IgE = Emergency"</h4>
        <p>IgE acts fastest (anaphylaxis) and is <b>E</b>levated in <b>E</b>czema/<b>E</b>osinophilia.</p>
        </div>
    </div>

    <div class="question-card">
        <h1>Question 2</h1>
        <p>Which antibody is MOST likely involved in immune complex-mediated vasculitis?</p>
        <ul class="options" id="options">
        <li data-answer="wrong">IgE</li>
        <li data-answer="correct">IgG</li>
        <li data-answer="wrong">IgD</li>
        </ul>
    </div>

    <!-- TYPE I HYPERSENSITIVITY -->
    <div class="explanation-card">
        <h1>Type I Hypersensitivity: Immediate (IgE-Mediated)</h1>
        <p><b>Pathophysiology</b>: Antigen (allergen) cross-links IgE on mast cells → <b>degranulation</b> → preformed mediator release (histamine, tryptase) and <b>new synthesis</b> (leukotrienes, PGD2).</p>

        <h2>Key Mediators</h2>
        <ol>
        <li><b>Histamine</b>: Vasodilation (flushing, hypotension), bronchoconstriction, pruritus.</li>
        <li><b>Leukotriene C4</b>: Sustained bronchospasm (asthma).</li>
        <li><b>TNF-α</b>: Recruits neutrophils/eosinophils (late-phase reaction).</li>
        </ol>

        <h2>Clinical Examples</h2>
        <ol>
        <li><b>Anaphylaxis</b>: Systemic (peanuts, venom).</li>
        <li><b>Allergic rhinitis</b>: Localized (pollen).</li>
        <li><b>Atopic dermatitis</b>: Chronic Th2-driven inflammation.</li>
        </ol>

        <div class="mnemonic">
        <h4>Mnemonic: "HALT" for Histamine Effects</h4>
        <p><b>H</b>ypotension | <b>A</b>ngioedema | <b>L</b>acrimation | <b>T</b>achycardia.</p>
        </div>
    </div>

    <div class="question-card">
        <h1>Question 3</h1>
        <p>Which mediator is primarily responsible for the late-phase reaction in asthma?</p>
        <ul class="options" id="options">
        <li data-answer="wrong">Histamine</li>
        <li data-answer="correct">Leukotriene C4</li>
        <li data-answer="wrong">Bradykinin</li>
        </ul>
    </div>

    <!-- TYPE II HYPERSENSITIVITY -->
    <div class="explanation-card">
        <h1>Type II Hypersensitivity: Antibody-Mediated Cytotoxicity</h1>
        <p><b>Pathophysiology</b>: IgG/IgM binds <b>cell-surface antigens</b> → destruction via:</p>
        <ol>
        <li><b>Complement activation</b> (MAC → cell lysis).</li>
        <li><b>Phagocytosis</b> (FcγR on macrophages).</li>
        <li><b>ADCC</b> (NK cells).</li>
        </ol>

        <h2>Clinical Examples</h2>
        <ol>
        <li><b>Autoimmune hemolytic anemia</b> (anti-RBC IgG).</li>
        <li><b>Graves’ disease</b> (TSHR-stimulating IgG).</li>
        <li><b>Myasthenia gravis</b> (anti-AChR IgG).</li>
        </ol>

        <div class="mnemonic">
        <h4>Mnemonic: "CELL" for Type II Targets</h4>
        <p><b>C</b>ells (RBCs, platelets) | <b>E</b>ndocrine (TSHR) | <b>L</b>igand receptors (AChR) | <b>L</b>ungs (Goodpasture’s).</p>
        </div>
    </div>

    <div class="question-card">
        <h1>Question 4</h1>
        <p>Which disease is caused by antibody-mediated stimulation of a receptor?</p>
        <ul class="options" id="options">
        <li data-answer="wrong">Pemphigus vulgaris</li>
        <li data-answer="correct">Graves’ disease</li>
        <li data-answer="wrong">Hashimoto’s thyroiditis</li>
        </ul>
    </div>

    <!-- TYPE III HYPERSENSITIVITY -->
    <div class="explanation-card">
        <h1>Type III Hypersensitivity: Immune Complex-Mediated</h1>
        <p><b>Pathophysiology</b>: Antigen-antibody (<b>IgG/IgM</b>) complexes deposit in tissues → <b>complement activation</b> (C5a → neutrophil recruitment) → inflammation and tissue damage. Key features:</p>

        <h2>Mechanistic Steps</h2>
        <ol>
            <li><b>Complex Formation</b>: Soluble antigen binds antibody in circulation.</li>
            <li><b>Deposition</b>: Complexes lodge in vascular beds (kidneys, joints, skin) due to <b>hemodynamic factors</b> (e.g., high pressure in glomeruli).</li>
            <li><b>Inflammation</b>: C3a/C5a attract neutrophils → release proteases/ROS → vessel damage (<b>vasculitis</b>).</li>
        </ol>

        <h2>Clinical Examples</h2>
        <ol>
            <li><b>Serum sickness</b>: Anti-foreign protein (e.g., horse antitoxin) complexes.</li>
            <li><b>SLE nephritis</b>: Anti-dsDNA/deposition in glomeruli.</li>
            <li><b>Cryoglobulinemic vasculitis</b>: Cold-precipitable IgM/IgG complexes.</li>
        </ol>

        <div class="mnemonic">
            <h4>Mnemonic: "SAD" for Type III Triggers</h4>
            <p><b>S</b>erum sickness | <b>A</b>utoimmunity (SLE) | <b>D</b>rugs (penicillin).</p>
        </div>
    </div>

    <div class="question-card">
        <h1>Question 5</h1>
        <p>Which lab finding is MOST suggestive of Type III hypersensitivity?</p>
        <ul class="options" id="options">
            <li data-answer="wrong">Elevated serum IgE</li>
            <li data-answer="correct">Low C3/C4 with anti-dsDNA</li>
            <li data-answer="wrong">Positive Coombs test</li>
        </ul>
    </div>

    <!-- TYPE IV HYPERSENSITIVITY -->
    <div class="explanation-card">
        <h1>Type IV Hypersensitivity: Delayed (T-Cell-Mediated)</h1>
        <p><b>Pathophysiology</b>: Antigen-specific <b>Th1/Th17 or cytotoxic CD8+ T cells</b> drive inflammation 48–72 hours post-exposure. No antibody involvement.</p>

        <h2>Subtypes and Mechanisms</h2>
        <ol>
            <li><b>Contact Dermatitis</b> (e.g., poison ivy): 
            Haptens bind skin proteins → <b>Langerhans cells</b> present antigen to Th1 → IFN-γ → epidermal spongiosis.</li>
            <li><b>Tuberculin Reaction</b> (PPD test): 
            Memory T cells recruit macrophages → granuloma formation.</li>
            <li><b>Drug-Induced Stevens-Johnson Syndrome</b>: 
            CD8+ T cells kill keratinocytes via <b>Fas-FasL</b>.</li>
        </ol>

        <h2>Clinical Examples</h2>
        <ol>
            <li><b>Allergic contact dermatitis</b> (nickel, urushiol).</li>
            <li><b>Type 1 diabetes mellitus</b> (insulitis).</li>
            <li><b>Graft rejection</b> (direct allorecognition).</li>
        </ol>

        <div class="mnemonic">
            <h4>Mnemonic: "T-Cells Take Time"</h4>
            <p>Type IV is <b>T</b>ardy (48+ hours), <b>T</b>issue-specific, and <b>T</b>reatable with immunosuppressants.</p>
        </div>
    </div>

    <div class="question-card">
        <h1>Question 6</h1>
        <p>Which cell is MOST critical in poison ivy dermatitis?</p>
        <ul class="options" id="options">
            <li data-answer="wrong">Mast cells</li>
            <li data-answer="correct">Th1 CD4+ T cells</li>
            <li data-answer="wrong">Neutrophils</li>
        </ul>
    </div>

    <!-- DIAGNOSTICS FOR ALL TYPES -->
    <div class="explanation-card">
        <h1>Diagnostic Approach to Hypersensitivity Reactions</h1>

        <h2>Type I (IgE-Mediated)</h2>
        <ol>
            <li><b>Skin prick testing</b>: Wheal/flare to allergens.</li>
            <li><b>Serum IgE</b>: Allergen-specific IgE (e.g., ImmunoCAP).</li>
            <li><b>Tryptase</b>: Elevated in anaphylaxis (mast cell degranulation).</li>
        </ol>

        <h2>Type II/III (Antibody-Mediated)</h2>
        <ol>
            <li><b>Direct Coombs test</b>: Detects anti-RBC IgG (autoimmune hemolysis).</li>
            <li><b>Anti-dsDNA/C3/C4</b>: Low C3/C4 in SLE nephritis.</li>
            <li><b>Cryoglobulins</b>: Precipitate at cold temperatures.</li>
        </ol>

        <h2>Type IV (T-Cell-Mediated)</h2>
        <ol>
            <li><b>Patch testing</b>: Delayed reaction to contact allergens.</li>
            <li><b>PPD skin test</b>: Induration ≥10 mm = prior TB exposure.</li>
            <li><b>Biopsy</b>: Lymphocytic infiltrate (e.g., spongiotic dermatitis).</li>
        </ol>
    </div>

    <div class="question-card">
    <h1>Question 7</h1>
        <p>A patient with SLE develops hematuria and proteinuria. Which test is MOST likely to reveal the cause?</p>
        <ul class="options" id="options">
            <li data-answer="wrong">Serum IgE levels</li>
            <li data-answer="correct">Anti-dsDNA antibodies and C3/C4</li>
            <li data-answer="wrong">Patch testing</li>
        </ul>
    </div>

    <!-- TREATMENT STRATEGIES -->
    <div class="explanation-card">
        <h1>Treatment of Hypersensitivity Reactions</h1>

        <h2>Type I</h2>
        <ol>
            <li><b>Anaphylaxis</b>: 
            <b>Epinephrine</b> (IM), antihistamines (H1/H2 blockers), glucocorticoids.</li>
            <li><b>Chronic atopy</b>: 
            <b>Allergen avoidance</b>, <b>omalizumab</b> (anti-IgE), leukotriene antagonists.</li>
        </ol>

        <h2>Type II/III</h2>
        <ol>
            <li><b>Autoimmune cytopenias</b>: 
            <b>IVIG</b> (blocks Fc receptors), <b>rituximab</b> (anti-CD20).</li>
            <li><b>SLE nephritis</b>: 
            <b>Mycophenolate</b>/<b>cyclophosphamide</b> + glucocorticoids.</li>
        </ol>

        <h2>Type IV</h2>
        <ol>
            <li><b>Contact dermatitis</b>: 
            Topical glucocorticoids, <b>calcineurin inhibitors</b> (tacrolimus).</li>
            <li><b>Graft rejection</b>: 
            <b>Calcineurin inhibitors</b> (cyclosporine), <b>anti-IL-2R</b> (basiliximab).</li>
        </ol>

        <div class="mnemonic">
            <h4>Mnemonic: "STOP" for Anaphylaxis Management</h4>
            <p><b>S</b>upplemental oxygen | <b>T</b>rendelenburg position | <b>O</b>xygen + fluids | <b>P</b>inephrine (IM thigh).</p>
        </div>
    </div>

    <div class="question-card">
        <h1>Question 8</h1>
        <p>Which drug is a first-line treatment for chronic IgE-mediated asthma?</p>
        <ul class="options" id="options">
            <li data-answer="wrong">Cyclophosphamide</li>
            <li data-answer="correct">Omalizumab</li>
            <li data-answer="wrong">Mycophenolate</li>
        </ul>
    </div>

    <div class="placeholder" id="empty">Test</div>

</div>